Jerry Wan
Fortune : 209 895 $ au 31/07/2026
Fortune : 209 895 $ au 31/07/2026
Jerry Wan is currently Vice President-Finance at Achieve Life Sciences, Inc. since 2025, with employment at the firm starting in 2017.
Formerly, Mr. Wan was Director-Accounting Operations at OncoGenex Pharmaceuticals, Inc. from 2014 to 2017 and Manager-Management Reporting at Gateway Casinos & Entertainment Ltd. from 2010 to 2011.
Education includes an undergraduate degree from the University of British Columbia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/01/2026 | 32 694 ( 0,03% ) | 209 895 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Corporate Officer/Principal | 01/02/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Directeur Financier/CFO | 01/07/2014 |
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Corporate Officer/Principal | 01/01/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national